YARW Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.